GSK signs a biomarker agreement with KineMed; Breath biomarkers could spot lung cancer;

> Biomarker company KineMed has signed a multiyear R&D collaboration with U.K.-based GlaxoSmithKline to find markers for muscle wasting, fibrosis and metabolic diseases. Press release

> A group of RNA-binding proteins might help track progression in Alzheimer's disease. Press release | Abstract

> A genetic variation linked to alcohol dependence could be a marker for the trait, as well as a target for treatment. Article

> The University of Oxford is using technology from Population Genetics to study gene variants and find biomarkers linked with myocardial infarction, diabetes and metabolic disease. Press release

> Companion Dx has gained a nonexclusive license to Epigenomics' DNA methylation biomarker Septin9 to develop a blood-based laboratory-developed test for colorectal cancer. Article

> bioTheranostics has expanded its Precis Precision Medicine biomarker profiles for non-small cell lung and colorectal cancers to 13 non-small cell lung and 7 colorectal cancer clinically relevant tumor biomarkers. Press release

And Finally… Dogs can smell lung cancer on people's breath, according to previous research; National Jewish Health and Metabolomx are looking for the breath biomarkers that make this possible. Press release

Suggested Articles

Spinal Elements, maker of a wide range of implants and products for minimally invasive spine procedures, has filed a $100 million IPO.

United Airlines will begin providing COVID-19 screening tests for passengers, allowing those who test negative to skip local quarantine requirements.

Babson Diagnostics has closed its series A funding round with a total of $13.7 million and named a new CEO.